Daniel A. Igel

Expression of NECTIN-4 and TROP-2 in Resected Upper Tract Urothelial Carcinoma with and Without Preoperative Chemotherapy

Background Antibody-drug conjugates (ADCs) have transformed the treatment of urothelial carcinoma, yet upper tract urothelial cancer (UTUC) data remain limited. Objective We compared NECTIN-4 and trophoblast cell-surface antigen 2 (TROP-2) expression in UTUC specimens from treatm...